February 12, 2018 / 9:29 AM / 6 months ago

BRIEF-Richter expects flat revenue in 2018 without Esmya

Feb 12 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt CEO Gabor Orban tells press briefing:

* EXPECTS 2018 GLOBAL REVENUE BROADLY UNCHANGED FROM 2017, CALCULATED WITHOUT FLAGSHIP DRUG ESMYA AND PROVIDED ROUBLE REMAINS BROADLY UNCHANGED

* EXPECTS REVENUE TO STAGNATE IN EASTERN EUROPE

* EXPECTS REVENUE TO REMIAN FLAT IN WESTERN EUROPE, NOT COUNTING ESMYA SALES

* UKRAINE REVENUE TO DROP 10 PCT Y/Y ON ONE-OFF

* CHINA, LATIN AMERICA TO POST 5 PCT GROWTH

* U.S. REVENUE TO SHOW 15 PCT Y/Y DECLINE WITHOUT VRAYLAR Further company coverage: (Reporting by Marton Dunai)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below